Literature DB >> 28755806

Physical activity and blood pressure in 10,000 Mediterranean adults: The EPIC-Florence cohort.

G Masala1, B Bendinelli1, D Occhini1, R M Bruno2, S Caini1, C Saieva1, A Ungar3, L Ghiadoni2, D Palli4.   

Abstract

BACKGROUND AND AIMS: The relevant role of physical activity (PA) in cardiovascular risk prevention is widely agreed. We aimed to evaluate, in a large Mediterranean population, the influence of PA on systolic (SBP) and diastolic blood pressure (DBP), taking into account individual characteristics and lifestyle habits. METHODS AND
RESULTS: In the Florence section of the European Prospective Investigation into Cancer and Nutrition 10,163 individuals, 35-64 years, without a previous diagnosis of hypertension were recruited. Information on occupational and leisure-time PA and blood pressure were collected at recruitment, together with data on lifestyle, dietary habits and anthropometry. Multivariate regression models were applied to evaluate the effect of total, occupational and leisure-time PA on SBP and DBP. Mean values of SBP and DBP in the study subjects were 124.4 (SD 15.6) and 79.7 mmHg (SD 9.4), respectively. Overall, a total PA index and an index including cycling, fitness and occupational PA (Cambridge index) were inversely associated with DBP (beta -0.87, p-value 0.02 actives vs inactives, p for trend 0.02 and beta -0.84, p value 0.003 actives vs inactives, p for trend 0.002, respectively), while SBP was associated only with the latter index (beta -1.14, p-value 0.01 actives vs inactives, p for trend 0.006). An inverse association emerged between manual/heavy manual occupation and DBP (p 0.02, ref sedentary/standing occupation) and between increasing cycling activity and SBP (p for trend 0.04).
CONCLUSIONS: In this large cohort of Mediterranean adults without a diagnosis of hypertension we confirm the role of overall PA in modulating SBP and DBP values. Cycling and manual occupations were associated with lower DBP values.
Copyright © 2017 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adults; Blood pressure; Cross-sectional studies; Exercise; Physical fitness

Mesh:

Year:  2017        PMID: 28755806     DOI: 10.1016/j.numecd.2017.06.003

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN: 0939-4753            Impact factor:   4.222


  5 in total

1.  The physical activity health paradox and risk factors for cardiovascular disease: A cross-sectional compositional data analysis in the Copenhagen City Heart Study.

Authors:  Melker S Johansson; Andreas Holtermann; Jacob L Marott; Eva Prescott; Peter Schnohr; Mette Korshøj; Karen Søgaard
Journal:  PLoS One       Date:  2022-04-21       Impact factor: 3.240

2.  Effect of a Primary Care-Based Chronic Disease Management Program for Hypertension Patients in South Korea.

Authors:  Eun-Whan Lee; Hee-Sun Kim; Bit-Na Yoo; Eun-Ji Lee; Jae Hyun Park
Journal:  Iran J Public Health       Date:  2022-03       Impact factor: 1.479

3.  Measuring Free-Living Physical Activity With Three Commercially Available Activity Monitors for Telemonitoring Purposes: Validation Study.

Authors:  Martine Jm Breteler; Joris H Janssen; Wilko Spiering; Cor J Kalkman; Wouter W van Solinge; Daan Aj Dohmen
Journal:  JMIR Form Res       Date:  2019-04-24

4.  Community Primary Care-Based Hypertension and Diabetes Management Program in Korea: Evaluation of Participating Patients and Doctors.

Authors:  Hee-Sun Kim; Bit-Na Yoo; Eun-Ji Lee; Eun-Whan Lee; Jae Hyun Park
Journal:  Iran J Public Health       Date:  2022-07       Impact factor: 1.479

5.  Relation Between Leisure Time, Commuting, and Occupational Physical Activity With Blood Pressure in 125 402 Adults: The Lifelines Cohort.

Authors:  Oyuntugs Byambasukh; Harold Snieder; Eva Corpeleijn
Journal:  J Am Heart Assoc       Date:  2020-02-12       Impact factor: 5.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.